Medirom Capital Lease Obligations vs Non Currrent Assets Other Analysis

MRM Stock  USD 5.93  0.12  2.07%   
Medirom Healthcare financial indicator trend analysis is infinitely more than just investigating Medirom Healthcare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medirom Healthcare is a good investment. Please check the relationship between Medirom Healthcare Capital Lease Obligations and its Non Currrent Assets Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Capital Lease Obligations vs Non Currrent Assets Other

Capital Lease Obligations vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medirom Healthcare Capital Lease Obligations account and Non Currrent Assets Other. At this time, the significance of the direction appears to have strong relationship.
The correlation between Medirom Healthcare's Capital Lease Obligations and Non Currrent Assets Other is 0.76. Overlapping area represents the amount of variation of Capital Lease Obligations that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Medirom Healthcare Technologies, assuming nothing else is changed. The correlation between historical values of Medirom Healthcare's Capital Lease Obligations and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Lease Obligations of Medirom Healthcare Technologies are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Capital Lease Obligations i.e., Medirom Healthcare's Capital Lease Obligations and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.76
Relationship DirectionPositive 
Relationship StrengthSignificant

Capital Lease Obligations

Medirom Healthcare capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Medirom Healthcare asset purchases. For example, Medirom Healthcare can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Medirom Healthcare control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Medirom Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medirom Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At this time, Medirom Healthcare's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 17th of May 2024, Enterprise Value Over EBITDA is likely to grow to 27.41, while Tax Provision is likely to drop about 33.7 M.
 2020 2021 2023 2024 (projected)
Gross Profit317.7M1.4B1.6B1.1B
Total Revenue1.4B5.4B6.2B4.3B

Medirom Healthcare fundamental ratios Correlations

0.650.810.99-0.470.51-0.810.65-0.760.52-0.540.980.610.92-0.470.410.670.64-0.190.810.480.88-0.720.93-0.160.82
0.650.130.64-0.7-0.25-0.460.99-0.080.980.210.7-0.040.890.270.870.040.04-0.830.18-0.330.79-0.210.840.530.18
0.810.130.84-0.280.9-0.830.11-0.950.0-0.910.80.660.54-0.88-0.150.930.630.370.930.890.5-0.880.64-0.511.0
0.990.640.84-0.550.57-0.870.62-0.790.52-0.590.990.540.91-0.530.360.730.56-0.160.830.520.84-0.780.94-0.140.87
-0.47-0.7-0.28-0.55-0.090.73-0.620.28-0.750.16-0.610.36-0.630.15-0.36-0.310.330.42-0.360.11-0.510.59-0.73-0.33-0.36
0.51-0.250.90.57-0.09-0.64-0.28-0.87-0.34-0.940.490.550.16-0.97-0.550.930.490.720.820.960.23-0.830.31-0.710.89
-0.81-0.46-0.83-0.870.73-0.64-0.410.85-0.390.74-0.87-0.31-0.710.7-0.1-0.76-0.31-0.01-0.88-0.53-0.620.93-0.820.24-0.86
0.650.990.110.62-0.62-0.28-0.41-0.070.960.230.690.030.890.310.91-0.010.11-0.860.16-0.330.78-0.150.820.530.16
-0.76-0.08-0.95-0.790.28-0.870.85-0.070.050.95-0.73-0.68-0.480.910.21-0.86-0.66-0.41-0.99-0.84-0.490.91-0.570.65-0.94
0.520.980.00.52-0.75-0.34-0.390.960.050.310.59-0.220.810.360.85-0.05-0.15-0.870.05-0.450.69-0.140.770.640.06
-0.540.21-0.91-0.590.16-0.940.740.230.950.31-0.52-0.58-0.210.990.48-0.87-0.53-0.64-0.9-0.92-0.210.86-0.340.73-0.89
0.980.70.80.99-0.610.49-0.870.69-0.730.59-0.520.470.94-0.450.450.680.5-0.260.770.440.83-0.740.97-0.030.83
0.61-0.040.660.540.360.55-0.310.03-0.68-0.22-0.580.470.34-0.52-0.030.481.00.30.660.680.42-0.350.28-0.640.6
0.920.890.540.91-0.630.16-0.710.89-0.480.81-0.210.940.34-0.130.710.410.4-0.560.560.120.9-0.520.970.20.58
-0.470.27-0.88-0.530.15-0.970.70.310.910.360.99-0.45-0.52-0.130.57-0.88-0.47-0.71-0.87-0.92-0.170.86-0.280.76-0.86
0.410.87-0.150.36-0.36-0.55-0.10.910.210.850.480.45-0.030.710.57-0.30.05-0.95-0.14-0.510.510.220.570.71-0.11
0.670.040.930.73-0.310.93-0.76-0.01-0.86-0.05-0.870.680.480.41-0.88-0.30.440.470.840.870.42-0.880.55-0.480.94
0.640.040.630.560.330.49-0.310.11-0.66-0.15-0.530.51.00.4-0.470.050.440.220.640.630.47-0.330.32-0.580.58
-0.19-0.830.37-0.160.420.72-0.01-0.86-0.41-0.87-0.64-0.260.3-0.56-0.71-0.950.470.220.320.72-0.38-0.32-0.43-0.810.33
0.810.180.930.83-0.360.82-0.880.16-0.990.05-0.90.770.660.56-0.87-0.140.840.640.320.770.59-0.920.64-0.630.92
0.48-0.330.890.520.110.96-0.53-0.33-0.84-0.45-0.920.440.680.12-0.92-0.510.870.630.720.770.13-0.690.23-0.710.86
0.880.790.50.84-0.510.23-0.620.78-0.490.69-0.210.830.420.9-0.170.510.420.47-0.380.590.13-0.550.88-0.060.53
-0.72-0.21-0.88-0.780.59-0.830.93-0.150.91-0.140.86-0.74-0.35-0.520.860.22-0.88-0.33-0.32-0.92-0.69-0.55-0.670.49-0.9
0.930.840.640.94-0.730.31-0.820.82-0.570.77-0.340.970.280.97-0.280.570.550.32-0.430.640.230.88-0.670.140.68
-0.160.53-0.51-0.14-0.33-0.710.240.530.650.640.73-0.03-0.640.20.760.71-0.48-0.58-0.81-0.63-0.71-0.060.490.14-0.46
0.820.181.00.87-0.360.89-0.860.16-0.940.06-0.890.830.60.58-0.86-0.110.940.580.330.920.860.53-0.90.68-0.46
Click cells to compare fundamentals

Medirom Healthcare Account Relationship Matchups

Medirom Healthcare fundamental ratios Accounts

201920202021202220232024 (projected)
Long Term Debt150.5M668.4M746.6M1.1B1.3B672.8M
Capital Lease Obligations1.8B1.7B1.9B2.0B1.8B1.5B
Net Invested Capital1.1B1.3B700.5M1.2B1.4B1.1B
Property Plant And Equipment Gross2.0B183.1M2.4B2.6B3.0B2.1B
Short Long Term Debt371.6M221.1M162.3M99.2M89.3M84.8M
Non Current Liabilities Other5.6M348.4M25.2M335.0M385.2M404.5M
Net Working Capital(884.0M)428.3M(1.8B)(1.3B)(1.2B)(1.2B)

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Medirom Healthcare using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Medirom Stock analysis

When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.05)
Revenue Per Share
1.4 K
Quarterly Revenue Growth
0.03
Return On Assets
(0.01)
Return On Equity
(7.00)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.